Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Amundi MSCI Semiconductors ESG

LYSM.SG•STU
Financial Services
Asset Management
€127.48
€-0.50(-0.39%)
German Market opens in 50h 8m

Amundi MSCI Semiconductors ESG Fundamental Analysis

Amundi MSCI Semiconductors ESG (LYSM.SG) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.
We analyze LYSM.SG's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
0.0/100

We analyze LYSM.SG's fundamental strength across five key dimensions:

Efficiency Score

Weak

LYSM.SG struggles to generate sufficient returns from assets.

ROA > 10%
N/A

Valuation Score

Weak

LYSM.SG trades at a premium to fair value.

PE < 25
N/A
PEG Ratio < 2
N/A

Growth Score

Weak

LYSM.SG faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

LYSM.SG carries high financial risk with limited liquidity.

Debt/Equity < 1
N/A
Current Ratio > 1
N/A

Profitability Score

Weak

LYSM.SG struggles to sustain strong margins.

ROE > 15%
N/A
Net Margin ≥ 15%
N/A
Positive Free Cash Flow
N/A

Key Financial Metrics

Is LYSM.SG Expensive or Cheap?

No data available.

How Well Does LYSM.SG Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How LYSM.SG Stacks Against Its Sector Peers

MetricLYSM.SG ValueSector AveragePerformance
P/E RatioN/A18.50 N/A
ROEN/A809.00% N/A
Net MarginN/A2211.00% N/A
Debt/EquityN/A0.90 N/A
Current RatioN/A692.04 N/A
ROAN/A-24328.00% (disorted) N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Amundi MSCI Semiconductors ESG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

Fundamental Analysis FAQ